See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Chemical Class · PPAR
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008043 |
10- |
88127-53-1 | ≥98% |
|
2006-08-01 | 33.116261510129 | 10-nitrooleate | 10-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 9-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | 33.116261510129 | ||
| 18570 |
15- |
87893-55-8 | ≥95% |
|
87.065636974572 | 15-deoxy-12-14-prostaglandin-j2 | 15-deoxy-Δ12,14-PGJ2 | PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis | 87.065636974572 | |||
| 18570.1 |
15- |
87893-55-8 | >98% (isomer mixture) |
|
72.258808208366 | 15-deoxy-12-14-prostaglandin-j2 | 15-deoxy-Δ12,14-PGJ2 | PPAR.gamma. PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands | 72.258808208366 | |||
| 10007235 |
15- |
87893-55-8 | ≥97% |
|
2009-01-16 | 38.002247928177 | 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard | 15-deoxy-Δ12,14-PGJ2 | PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards | 38.002247928177 | ||
| 90500 |
3- |
116296-31-2 | ≥98% |
|
2004-02-06 | 1.169668508287 | 3-thiatetradecanoic-acid | 3-TDA | thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis | 1.169668508287 | ||
| 10008042 |
9- |
875685-44-2 | ≥98% |
|
2006-08-11 | 28.305948434622 | 9-nitrooleate | 9-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 10-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | 28.305948434622 | ||
| 13452 | AM3102 Exclusive | 213182-22-0 | ≥98% |
|
✓ | 2009-08-11 | 40.003752932898 | am3102 | KDS-5104 | OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic | 40.003752932898 | |
| 10005292 | Atherosclerosis Product Pack | - | 2004-09-09 | 4.426165745856 | atherosclerosis-product-pack | Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs | 4.426165745856 | |||||
| 60924 | Azelaoyl PAF | - | >98% |
|
43.427316495658 | azelaoyl-paf | PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors | 43.427316495658 | ||||
| 10009145 | Bezafibrate | 41859-67-0 | ≥98% |
|
2007-08-02 | 4.950850828729 | bezafibrate | Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate | PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate | 4.950850828729 | ||
| 18210 | Carbaprostacyclin | 69552-46-1 | >99% |
|
82.885651144435 | carbaprostacyclin | Carbacyclin; cPGI | analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin | 82.885651144435 | |||
| 9000183 | Carbaprostacyclin methyl ester Exclusive | 69552-55-2 | ≥98% |
|
✓ | 2010-11-29 | 20.166906077348 | carbaprostacyclin-methyl-ester | prostacyclins prostaglandins I2 PGI2 IPs PPARδ stable analog activate activation | 20.166906077348 | ||
| 18590 | CAY10410 | 596104-94-8 | ≥98% (isomer mixture) |
|
74.621583793738 | cay10410 | 9,10-dihydro-15-deoxy-Δ12,14-Prostaglandin J2; 9,10-dihydro-15-deoxy-Δ12,14-PGJ2 | PPAR.gamma. PPARgamma prostaglandins 9,10-dihydro-15-deoxy-delta12,14-PGJ2 9,10-dihydro-15-deoxy-d12,14-PGJ2 9,10-dihydro-15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands oxidative stress | 74.621583793738 | |||
| 71748 | CAY10415 Exclusive | 146062-49-9 | ≥98% |
|
✓ | 2008-07-28 | 71.701507059545 | cay10415 | thiazolidinediones TZDs PPARgamma PPARg PPAR.gamma. antidiabetic anti-diabetic insulin blood glucose resistance lipogenesis peroxisome proliferators activated receptors | 71.701507059545 | ||
| 10009079 | CAY10506 Exclusive | 292615-75-9 | ≥98% |
|
✓ | 2008-11-17 | 30.623618784530 | cay10506 | diabetes glucose metabolism TZDs PPARγ agonists α-lipoic acids anti-diabetic | 30.623618784530 | ||
| 10009017 | CAY10514 | 868526-38-9 | ≥98% |
|
2007-01-24 | 5.527983425414 | cay10514 | Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate | peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis | 5.527983425414 | ||
| 10008846 | CAY10573 Exclusive | 853652-40-1 | ≥98% |
|
✓ | 2009-02-02 | 38.681650552486 | cay10573 | PPARs rosiglitazone diabetes PPARα PPARδ PPARγ | 38.681650552486 | ||
| 10012536 | CAY10592 Exclusive | 685139-10-0 | ≥98% |
|
✓ | 2009-02-26 | 26.856961325966 | cay10592 | selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn | 26.856961325966 | ||
| 13282 | CAY10599 Exclusive | 1143573-33-4 | ≥98% |
|
✓ | 2009-07-21 | 39.161461019030 | cay10599 | thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs | 39.161461019030 | ||
| 71730 | Ciglitazone | 74772-77-3 | ≥98% |
|
45.614659811745 | ciglitazone | U-63287; ADD 3878 | nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology | 45.614659811745 | |||
| 10956 | Clofibrate | 637-07-0 | ≥98% |
|
2004-09-14 | 10.768753836709 | clofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate | 10.768753836709 | |||
| 10007614 | FABP4 (human) EIA Kit | - |
|
2006-10-13 | 21.150617581095 | fabp4-human-eia-kit | Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte FABP (human) EIA Kit; A-FABP (human) ELISA Kit; aP2 | 10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays | 21.150617581095 | |||
| 10004944 | FABP4 Polyclonal Antibody | - | 2004-11-05 | 12.961649565904 | fabp4-polyclonal-antibody | Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP; Adipocyte-FABP | atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting | 12.961649565904 | ||||
| 10005368 | Fenofibrate | 49562-28-9 | ≥98% |
|
2004-09-15 | 12.769097605892 | fenofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology | 12.769097605892 | |||
| 10009880 | GW 590735 Exclusive | 622402-22-6 | ≥98% |
|
✓ | 2007-06-18 | 9.053149171270 | gw-590735 | PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology | 9.053149171270 | ||
| 10008613 | GW 7647 | 265129-71-3 | ≥98% |
|
2006-08-02 | 21.838997632202 | gw-7647 | PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 | 21.838997632202 | |||
| 10011211 | GW 9578 Exclusive | 247923-29-1 | ≥98% |
|
✓ | 2008-05-23 | 26.156961325966 | gw-9578 | atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated | 26.156961325966 | ||
| 70785 | GW 9662 | 22978-25-2 | ≥98% |
|
71.039342541436 | gw-9662 | GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis | 71.039342541436 | ||||
| 9000497 |
GW 9662- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2009-09-30 | 33.777096378146 | gw-9662-d5 | deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs | 33.777096378146 | ||
| 70270 | Indomethacin | 53-86-1 | ≥99% |
|
29.233316340602 | indomethacin | Indocin | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry | 29.233316340602 | |||
| 101730 | MCAD Polyclonal Antibody | - | 10.273922651933 | mcad-polyclonal-antibody | Medium-chain Fatty Acyl-CoA Dehydrogenase | antisera dehydrogenases peroxisome proliferator-activated receptors response element nuclear reactors PPARalpha PPAR.alpha. PPRE human beta-oxidation b-oxidation .beta.-oxidation western blots blotting antibody antibodies WB immunoblotting | 10.273922651933 | |||||
| 301707 |
PGC- |
- | 2006-07-25 | 11.767955801105 | pgc-1-blocking-peptide | antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity | 11.767955801105 | |||||
| 101707 |
PGC- |
- |
|
2005-10-12 | 27.193957810145 | pgc-1-polyclonal-antibody | PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 | atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting | 27.193957810145 | |||
| 10044 | PGPC | 89947-79-5 | >98% |
|
2004-01-21 | 3.828968692449 | pgpc | PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding | 3.828968692449 | |||
| 71745 | Pioglitazone | 111025-46-8 | >98% |
|
24.079289660615 | pioglitazone | PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated rosiglitazone receptors activation selectively selectivity | 24.079289660615 | ||||
| 10028 | Pioglitazone (potassium salt) | - | >98% |
|
36.995177584846 | pioglitazone-potassium-salt | PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated receptors | 36.995177584846 | ||||
| 301710 | PPARα Blocking Peptide | - | 7.624732965009 | ppar-blocking-peptide | Peroxisome Proliferator-activated Receptor α | peroxisome proliferator-activated receptors peptides controls pparalpha ppar.alpha. antibodies nuclear reactors | 7.624732965009 | |||||
| 10009088 | PPARα LBD (human recombinant) | - | ≥90% | 2006-09-13 | 56.225207182320 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor α Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting | 56.225207182320 | |||
| 101710 | PPARα Polyclonal Antibody | - |
|
26.564855739717 | ppar-polyclonal-antibody | Peroxisome Proliferator-activated Receptor α | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis | 26.564855739717 | ||||
| 10006915 | PPARα Transcription Factor Assay Kit | - |
|
2005-08-25 | 55.515160870978 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 55.515160870978 | |||
| 10008878 | PPARα, δ, γ Complete Transcription Factor Assay Kit | - |
|
2006-08-22 | 38.534629044988 | ppar-complete-transcription-factor-assay-kit | PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric | 38.534629044988 | ||||
| 301700 | PPARγ Blocking Peptide | - | 5.718549723756 | ppar-blocking-peptide | Peroxisome Proliferator-activated Receptor γ | peroxisome proliferators activated receptors controls immunohistochemistry IHC Western blotting WB PPAR.gamma. PPARgamma blots peptides antibodies | 5.718549723756 | |||||
| 61700 | PPARγ FL (human recombinant from E. coli) | - | >90% by SDS-PAGE |
|
2007-01-10 | 27.604745242480 | ppar-fl-human-recombinant-from-e-coli | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone | 27.604745242480 | ||
| 10009987 | PPARγ FL (human recombinant from Sf21 cells) | - | ≥80% by SDS-PAGE |
|
2007-06-15 | 33.559779005524 | ppar-fl-human-recombinant-from-sf21-cells | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) | proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology | 33.559779005524 | ||
| 10007941 | PPARγ LBD (human recombinant) | - | ≥90% |
|
2006-03-16 | 20.752995702885 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent | 20.752995702885 | ||
| 71000 | PPARγ Ligand Pack | - | >98% | 44.918631062001 | ppar-ligand-pack | Peroxisome Proliferator-activated Receptor γ Pack | ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs | 44.918631062001 | ||||
| 101700 | PPARγ Polyclonal Antibody | - |
|
18.013737174427 | ppar-polyclonal-antibody | Peroxisome Proliferator-activated Receptor γ | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors | 18.013737174427 | ||||
| 10006855 | PPARγ Transcription Factor Assay Kit | - |
|
2005-08-25 | 58.531583793738 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 58.531583793738 | |||
| 10006247 | PPARδ Blocking Peptide | - | >70% | 2004-11-09 | 2.702154696132 | ppar-blocking-peptide | PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 | controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 | 2.702154696132 | |||
| 10007451 | PPARδ (human recombinant) | - | ≥95% | 2005-07-29 | 13.889472068754 | ppar-human-recombinant | NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 | 13.889472068754 | |||
| 101720 | PPARδ Polyclonal Antibody | - |
|
2004-11-05 | 14.570783525866 | ppar-polyclonal-antibody | Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ | PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies | 14.570783525866 | |||
| 10006914 | PPARδ Transcription Factor Assay Kit | - |
|
2005-08-23 | 30.800928867402 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 30.800928867402 | |||
| 10009568 | PPARδ Western Ready Control | - | 2007-02-02 | 3.709790055248 | ppar-western-ready-control | Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity | 3.709790055248 | ||||
| 71740 | Rosiglitazone | 122320-73-4 | ≥98% |
|
156.772103540003 | rosiglitazone | BRL 49653 | BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology | 156.772103540003 | |||
| 10011343 |
Rosiglitazone- |
- | >99% deuterated product |
|
2009-04-04 | 37.339193370166 | rosiglitazone-d5-maleate | SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory | 37.339193370166 | |||
| 71742 | Rosiglitazone (potassium salt) | 316371-84-3 | >98% |
|
62.633134103465 | rosiglitazone-potassium-salt | BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology | 62.633134103465 | ||||
| 10026 | T0070907 | 313516-66-4 | ≥98% |
|
44.348055248618 | t0070907 | T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology | 44.348055248618 | ||||
| 71750 | Troglitazone | 97322-87-7 | >98% |
|
69.170685082872 | troglitazone | ResulinTM | antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology | 69.170685082872 | |||
| 70730 | Wy 14643 | 50892-23-4 | ≥98% |
|
55.026270718232 | wy-14643 | Pirinixic Acid | activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 | 55.026270718232 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search